Meralgia paresthetica (MP) is one of the most common peripheral entrapment neuropathies of the lower limbs. It is characterized by paresthesia, pain, tingling, numbness, hypersensitivity, or other abnormal skin sensations on the anterolateral aspect of the thigh. The condition results from compression of the lateral femoral cutaneous nerve (LFCN) along its course, often occurring as the nerve exits the pelvis.The injection of 5% dextrose (D5W) under ultrasound guidance is a novel treatment method for peripheral nerve entrapment. However, there is limited evidence about the efficacy of this method for patients with MP. The investigators found D5W was more safe and effective than corticosteroids for patients with MP. Thus, this study aimed to evaluate the 6-month efficacy of ultrasound-guided injection of D5W for MP patients.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
40
10ml D5W injection for MP patients
Peking University People's Hospital
Beijing, Beijing Municipality, China
visual analogue scale(VAS)
VAS is one of the most common tool to assess pain severity for patients, ranging from 0(no pain) to 10(most possible pain).
Time frame: baseline as well as 1month, 3 month, 6 months post-injection
cross-sectional area(CSA) of the nerve
CSA could reflect the compression of the nerve, to some extent
Time frame: baseline as well as 1month, 3 month, 6 months post-injection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.